Rybelsus Semaglutide Tablets

Rybelsus is an oral GLP-1 receptor agonist containing Semaglutide, primarily used for the management of Type 2 Diabetes Mellitus in adults. It helps improve glycemic control by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying.

Product Details

• Brand Name: Rybelsus®

• Generic Name: Semaglutide

• Dosage Form: Tablets

• Available Strengths: 3 mg, 7 mg, 14 mg

• Packaging: Strip / Box (as per availability)

• Administration Route: Oral

• Manufacturer: Novo Nordisk

Key Benefits

• Helps effectively control blood sugar levels

• Oral alternative to injectable GLP-1 therapies

• Supports weight reduction in Type 2 diabetes patients

• Once-daily dosing for better patient compliance

• Clinically proven and globally trusted molecule

Indications

• Type 2 Diabetes Mellitus (along with diet and exercise)

• Improves glycemic control in adult patients

Usage & Dosage

• To be taken once daily on an empty stomach

• Swallow whole with a small amount of water

• Dosage as prescribed by a healthcare professional

Storage Instructions

• Store below 30°C

• Keep away from moisture and direct sunlight

• Keep out of reach of children

Safety Information

• Prescription medicine – to be used under medical supervision

• Not recommended for Type 1 diabetes or diabetic ketoacidosis

• Inform your doctor about any medical conditions before use